KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Cash from Investing Activities (2016 - 2025)

Charles River Laboratories International has reported Cash from Investing Activities over the past 17 years, most recently at -$92.8 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$92.8 million for Q4 2025, down 21.95% from a year ago — trailing twelve months through Dec 2025 was -$209.3 million (up 14.59% YoY), and the annual figure for FY2025 was -$209.3 million, up 14.59%.
  • Cash from Investing Activities for Q4 2025 was -$92.8 million at Charles River Laboratories International, down from -$33.7 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for CRL hit a ceiling of $44.4 million in Q4 2022 and a floor of -$954.2 million in Q2 2021.
  • Median Cash from Investing Activities over the past 5 years was -$82.7 million (2023), compared with a mean of -$153.2 million.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 3233.31% in 2021 and later skyrocketed 376.88% in 2022.
  • Charles River Laboratories International's Cash from Investing Activities stood at $9.3 million in 2021, then skyrocketed by 376.88% to $44.4 million in 2022, then plummeted by 637.08% to -$238.4 million in 2023, then skyrocketed by 68.07% to -$76.1 million in 2024, then fell by 21.95% to -$92.8 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$92.8 million (Q4 2025), -$33.7 million (Q3 2025), and -$37.3 million (Q2 2025) per Business Quant data.